The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE)
The aim of this study was to present our preliminary experience with transarterial radioembolization (TARE) using Yttrium-90 (<sup>90</sup>Y), compare the cancer-specific survival (CSS) of patients with hepatocellular carcinoma (HCC) and colorectal cancer (CRC) liver metastases undergoin...
Main Authors: | Natale Quartuccio, Salvatore Ialuna, Daniele Scalisi, Fabio D’Amato, Maria Rosa Barcellona, Maria Grazia Bavetta, Giorgio Fusco, Enrico Bronte, Emma Musso, Fabrizio Bronte, Viviana Picciotto, Antonio Carroccio, Francesco Verderame, Giuseppe Malizia, Angelina Cistaro, Fabio La Gattuta, Antonino Maria Moreci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/31/3/114 |
Similar Items
-
Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
by: Amelia Wong, et al.
Published: (2024-08-01) -
Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility
by: Qian Yu, et al.
Published: (2023-11-01) -
Radioembolization for the treatment of hepatocellular carcinoma
by: Hyo-Cheol Kim
Published: (2017-06-01) -
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization
by: Ken Zhao, et al.
Published: (2024-05-01) -
Liver Radioembolization: a New Chapter in Russian Oncology
by: A. D. Kaprin, et al.
Published: (2019-12-01)